SCHEMBL2627962

SCHEMBL2627962

COC(=O)Cc1ccccc1CN1CCOCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A13 Q16696 5/20 0.55
HCRTR1 O43613 1/20 0.51
HCRTR2 O43614 1/20 0.51
CYP2C9 P11712 2/20 0.47
ALOX15 P16050 1/20 0.47
HSD17B10 Q99714 1/20 0.47
PDE10A Q9Y233 1/20 0.47
NPC1 O15118 1/20 0.46
HTT P42858 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C19 P33261 1/20 0.46
HRH3 Q9Y5N1 1/20 0.46
KDM4E B2RXH2 1/20 0.46
TSHR P16473 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
KMT2A Q03164 1/20 0.45
LIPE Q05469 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL890076 0.84 CYP2A13 (0.59) CYP2A13HCRTR1HCRTR2CYP2C9ALOX15
SCHEMBL304670 0.82 CYP2A13 (0.57) CYP2A13CYP2C9ALOX15HSD17B10NPC1
SCHEMBL888767 0.81 CYP2A13 (0.56) CYP2A13CYP2C9ALOX15HSD17B10NPC1
SCHEMBL10150886 0.81 CYP2A13 (0.56) CYP2A13HCRTR1HCRTR2CYP2C9ALOX15
SCHEMBL5216465 0.80 HCRTR1 (0.60) CYP2A13HCRTR1HCRTR2CYP2C9ALOX15
SCHEMBL8907096 0.80 CYP2A13 (0.55) CYP2A13CYP2C9ALOX15HSD17B10NPC1
SCHEMBL15391665 0.79 SMN1; SMN2 (0.60) NPC1HTTRAB9ASMN1; SMN2HRH3
SCHEMBL11193326 0.79 CYP2A13 (0.75) CYP2A13CYP2C9ALOX15HSD17B10HTT
SCHEMBL6756721 0.78 KDM4E (0.60) SMN1; SMN2CYP2D6CYP2C19HRH3KDM4E
SCHEMBL4108619 0.78 CYP2A13 (0.69) CYP2A13CYP2C9ALOX15HSD17B10HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2245027-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2012-04-25 EP disclosed